Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / NBIO - Nascent to get US patent linked to brain cancer drug pritumumab

NBIO - Nascent to get US patent linked to brain cancer drug pritumumab

Nascent Biotech

  • Nascent Biotech ( OTCQB:NBIO ) said the U.S. Patent and Trademark Office (USPTO) will issue a patent covering claims related to the monoclonal antibody pritumumab.
  • The U.S. patent No. 11,492,394, titled 'Kits and containers for treating vimentin expressing tumors,' provides broad protection for pritumumab (PTB) and the storage conditions related to its use in clinical applications, according to the company.
  • The patent will be issued on Nov. 8.
  • "This issuance strengthens our growing IP portfolio in our brain cancer treatment using Pritumumab, a unique natural antibody that crosses the blood brain barrier," said Nascent CEO Sean Carrick.
  • Pritumumab is being studied in phase 1 trials to treat brain cancer.

For further details see:

Nascent to get US patent linked to brain cancer drug pritumumab
Stock Information
Company Name: Nascent Biotech
Stock Symbol: NBIO
Market: OTC
Website: nascentbiotech.com
Menu
NBIO NBIO Quote NBIO Short NBIO News NBIO Articles NBIO Message Board
Get NBIO Alerts

News, Short Squeeze, Breakout and More Instantly...